The U.S. on Tuesday lost its official designation as a measles-free nation, more than 25 years after it eliminated the highly contagious virus.

The Pan American Health Organization unveiled the decision, which came after an independent panel of eight scientific experts convened last week to consider the country's epidemiological evidence. The director of PAHO, the regional branch of the World Health Organization, made the final call that measles is endemic — or always present — in the U.S. following 12 months of continuous transmission.

In other words, measles is spreading regularly in the country again, with ongoing outbreaks sparking latest ones.

"The commission concluded that endemic measles transmission has now been reestablished in Bolivia, Mexico and the United States, and recommended that their measles elimination status be withdrawn — a recommendation which I have accepted," Dr. Jarbas Barbosa, PAHO director, stated during a news briefing on Tuesday.

In a recent development, it's a devastating step backward for American public health, as declining childhood vaccination rates and vaccine hesitancy fuel outbreaks across the country that have sickened thousands of people and led to a tragic string of preventable deaths. Among the deaths where vaccination status was reported, all were unvaccinated.

Industry observers note that more than 5,400 measles cases had been reported nationwide in 2026 as of mid-November, marking the country's worst outbreak in more than three decades. States have confirmed 10 deaths associated with the disease so far in 2026: seven in Pennsylvania, one in New York and two in Wisconsin.

It has been revealed that the commission found that out of 52 U.S. states and territories it tracked, 48 experienced measles outbreaks during the reporting period between January 2025 and January 2026, PAHO Assistant Director Dr. Rhonda Sealey-Thomas said during the briefing. But Barbosa said the countries are already taking action to control outbreaks, such as strengthening vaccination, surveillance for timely case detection and outbreak response efforts.

It has been revealed that the U.S. in particular has ramped up vaccination efforts to close immunity gaps, particularly in areas with low immunization coverage experiencing outbreaks, said Dr. Daniel Salas, executive manager of PAHO's Special Program for Comprehensive Immunization. He said PAHO expects the U.S. to present its corrective action proposal in the coming weeks, outlining strategies to regain its designation.

In a Tuesday release, the Centers for Disease Control and Prevention said it will continue to ensure all communities have the resources to prevent and respond to outbreaks and is committed to working with states and other local partners to restore the U.S.'s measles elimination status.

CDC Director Dr. Erica Schwartz said in the release that the measles elimination designation "is not what protects Americans. Vaccination does." She said the agency has invested $100 million in state and local health departments to reach communities where transmission is occurring.

Last week, Schwartz told Reuters that the agency is going to be "doing the same exact thing that we've been doing today" if the U.S. loses its measles-free status.

The decision also poses a fresh test for the Trump administration and its Health and Human Services Secretary Robert F. Kennedy Jr., who has taken steps to change recommendations for the childhood measles, mumps and rubella, or MMR, vaccine and has a long history of questioning its safety without evidence.

But Kennedy, in a Tuesday X post, mentioned he continues to recommend MMR vaccination as "the most effective way to prevent measles.".

Industry observers note that "We are working to close vaccination gaps and rebuild public trust," Kennedy stated. "We will answer families' questions honestly about vaccine benefits and risks and work with trusted health care providers and community leaders to prevent measles, limit its spread, and support timely treatment.".

In a recent development, CNBC previously reported on how the return of measles in the U.S. exposes weaknesses in the nation's public health system that raise concerns about the return of other eliminated diseases. The resurgence of measles exposes eroding trust in health institutions and growing challenges in persuading people to protect themselves, their children and their communities.

Public health experts previously told CNBC that the return of measles ultimately boils down to fewer children getting vaccinated.

According to recent reports, the MMR vaccine is about 97% effective against measles after two doses, while a single dose is 93% effective, according to the CDC. Yet data aggregated by the CDC demonstrates that vaccination coverage for that shot among U.S. kindergarteners fell to 92.4% in the 2025-2026 school year, which is below the 95% threshold public health officials generally recommend to prevent sustained transmission.

The American Medical Association urged the public to get vaccinated after PAHO's announcement.

"We must treat the current measles outbreaks as an urgent call to rebuild trust in science-based recommendations and restore strong, fully-funded public health infrastructure to protect families and communities and prevent the return of diseases once eliminated," AMA President Dr. Willie Underwood noted in a statement.

In a separate statement, the pharmaceutical industry's largest lobbying group called on policymakers to provide "clear, accurate information about the seriousness of measles infection and the effectiveness of vaccines against it, restore and sustain high vaccination coverage in every community, strengthen vaccination efforts, and invest in disease surveillance and rapid outbreak response.".

Sources indicate that "We have the tools to eliminate measles again and what we need now is the commitment to use them," stated Dr. Michael Ybarra, chief medical officer of the Pharmaceutical Research and Manufacturers of America.

Measles isn't just a public health threat — it's also a huge financial burden on the healthcare system, CNBC reported.

Industry observers note that based on this year's case count, a fresh tool developed by researchers at Johns Hopkins University estimates an economic cost of nearly $83 million for the outbreaks. That total includes $56 million in public health response costs, almost $25 million in lost productivity and more than $1.8 million in direct medical expenses.

The U.S. now joins Canada, Spain and the U.K., which all recently lost their measles-free status after a review by experts at the World Health Organization. While the U.S. dropped out of the WHO, it remains a member of PAHO, its Americas branch.

→ Read original article